CEACAM5 and pancreatic neoplasm: Though galectins alone may not be an effective independent prognostic biomarker for pancreatic cancer compared to the performance of traditional clinical biomarkers such as CA19-9 and carcinoembryonic antigen (CEA) [69], the strategy to combine galectins with other biomarkers is worth consideration.